Skip to Content

Bumetanide Injection

Last Updated: March 28, 2018
Status: Resolved

Bumetanide Injection

Products Affected - Description
  • Bumetanide injection, Pfizer
    0.25 mg/mL, 4 mL vial, 10 count (NDC 00409-1412-04)

0.25 mg/mL, 10 mL vial, 10 count (NDC 00409-1412-10)
 
Bumetanide injection, West-Ward
0.25 mg/mL, 4 mL vial, 10 count (NDC 00641-6008-10)
0.25 mg/mL, 10 mL vial, 10 count (NDC 00641-6007-10)
Reason for the Shortage
    • Pfizer has bumetanide injection on shortage due to manufacturing delays.
    • West-Ward did not provide a reason for the shortage.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Pfizer has bumetanide 0.25 mg/mL 4 mL and 10 mL vials on back order and the company estimates a release date of June 2019.
    • West-Ward has bumetanide 0.25 mg/mL 4 mL and 10 mL vials on a weekly allocation.

Updated

March 28 and 6, February 5, January 16, 2018; November 10, October 4, August 29 and 7, July 10 and 7, June 21 and 9, May 8 and 4, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide